|
Volume 270,
Number 34,
Issue of August 25, pp. 19716-19722, 1995
©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Analysis of
the Short Consensus Repeats of Human Complement Factor B by
Site-directed Mutagenesis
(Received for publication, February 27, 1995; and in revised form, June 8, 1995)
Dennis E.
Hourcade ,
Lynne M.
Wagner,
Teresa
J.
Oglesby
Human factor B is required for the initiation and propagation of
the complement alternative pathway. It also participates in the
amplification of the complement classical pathway. Alone, factor B is a
zymogen with little known biochemical activity, but in the context of
the alternative pathway convertases, the factor B serine protease is
activated in a process that first involves the association with C3b and
subsequently the cleavage of factor B into two fragments, Ba and Bb.
Ba, the NH -terminal fragment, is composed mainly of three
tandem short consensus repeats, globular domains found in other
complement proteins. It dissociates from the convertase during
assembly, leaving the active C3 convertase, C3bBb. Previous reports
suggest that the Ba region may be instrumental in convertase assembly.
This hypothesis was tested using site-directed mutagenesis of
recombinant factor B and monoclonal antibody epitope mapping to
evaluate the relative importance of specific short consensus repeat
amino acid residues. Three sites of interest were identified. Site 1 is
a stretch of 19 contiguous amino acids in short consensus repeat 1 that
form the epitope of a monoclonal antibody that effectively blocks
factor B function. Site 2, composed of 6 contiguous amino acids in
short consensus repeat 2, and site 3, consisting of 7 contiguous amino
acids in short consensus repeat 3, were defined by mutations that
reduce factor B hemolytic activity to 3% or less. Further analyses
indicated that sites 2 and 3 contribute to factor B-C3b interactions.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Torreira, A. Tortajada, T. Montes, S. R. de Cordoba, and O. Llorca
3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase
PNAS,
January 20, 2009;
106(3):
882 - 887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Hourcade
The Role of Properdin in the Assembly of the Alternative Pathway C3 Convertases of Complement
J. Biol. Chem.,
January 27, 2006;
281(4):
2128 - 2132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Kuttner-Kondo, M. P. Dybvig, L. M. Mitchell, N. Muqim, J. P. Atkinson, M. E. Medof, and D. E. Hourcade
A Corresponding Tyrosine Residue in the C2/Factor B Type A Domain Is a Hot Spot in the Decay Acceleration of the Complement C3 Convertases
J. Biol. Chem.,
December 26, 2003;
278(52):
52386 - 52391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Xu, M. Ma, G. C. Ippolito, H. W. Schroeder Jr., M. C. Carroll, and J. E. Volanakis
Complement activation in factor D-deficient mice
PNAS,
November 20, 2001;
(2001)
261428398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Krych-Goldberg, R. E. Hauhart, V. B. Subramanian, B. M. Yurcisin II, D. L. Crimmins, D. E. Hourcade, and J. P. Atkinson
Decay Accelerating Activity of Complement Receptor Type 1 (CD35). TWO ACTIVE SITES ARE REQUIRED FOR DISSOCIATING C5 CONVERTASES
J. Biol. Chem.,
October 29, 1999;
274(44):
31160 - 31168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Hourcade, L. M. Mitchell, and T. J. Oglesby
Mutations of the Type A Domain of Complement Factor B That Promote High-Affinity C3b-Binding
J. Immunol.,
March 1, 1999;
162(5):
2906 - 2911.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Smith, C.-S. Shih, and S. G. Dachenhausen
Coelomocytes Express SpBf, a Homologue of Factor B, the Second Component in the Sea Urchin Complement System
J. Immunol.,
December 15, 1998;
161(12):
6784 - 6793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Hourcade, L. M. Mitchell, and T. J. Oglesby
A Conserved Element in the Serine Protease Domain of Complement Factor B
J. Biol. Chem.,
October 2, 1998;
273(40):
25996 - 26000.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Hourcade, L. Mitchell, L. A. Kuttner-Kondo, J. P. Atkinson, and M. E. Medof
Decay-accelerating Factor (DAF), Complement Receptor 1 (CR1), and Factor H Dissociate the Complement AP C3 Convertase (C3bBb) via Sites on the Type A Domain of Bb
J. Biol. Chem.,
January 4, 2002;
277(2):
1107 - 1112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Xu, M. Ma, G. C. Ippolito, H. W. Schroeder Jr., M. C. Carroll, and J. E. Volanakis
Complement activation in factor D-deficient mice
PNAS,
December 4, 2001;
98(25):
14577 - 14582.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|